AOA Dx Appoints Chris Roberts as Chief Product Officer to Advance Next-Generation Ovarian Cancer Diagnostics
Seasoned diagnostics leader brings deep expertise in product strategy, commercialization, and market access to launch AKRIVIS GD™ for commercial adoption.